Met Signaling Cascade Is Amplified by the Recruitment of Phosphorylated Met to Lipid Rafts via CD24 and Leads to Drug Resistance in Endometrial Cancer Cell Lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Met Signaling Cascade Is Amplified by the Recruitment of Phosphorylated Met to Lipid Rafts via CD24 and Leads to Drug Resistance in Endometrial Cancer Cell Lines

Published:2015-07-30 Issue:10 Volume:14 Page:2353-2363
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Ono Yoshihiro Joshua,Tanabe Akiko,Tanaka Tomohito,Tanaka Yoshimichi,Hayashi Masami,Terai Yoshito,Ohmichi Masahide

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200;International Journal of Molecular Sciences;2023-10-11

2. CD24 blockade as a novel strategy for cancer treatment;International Immunopharmacology;2023-08

3. New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways;Cancers;2022-11-26

4. The lipid rafts in cancer stem cell: a target to eradicate cancer;Stem Cell Research & Therapy;2022-08-30

5. CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance;Pharmacogenomics and Personalized Medicine;2021-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP